Tag Archives: AUTM

Five Steps to Restoring an Effective University IP Practice, Steps 1 and 2

Over the past couple of years, I have been involved in projects based in the idea of commons for the exchange of research and diagnostic assets. These projects have been blocked or resisted at each point by organizational technology transfer … Continue reading

Posted in Freedom, Policy | Tagged , , , , | Comments Off on Five Steps to Restoring an Effective University IP Practice, Steps 1 and 2

AUTM weighs in on march-in for remdesivir

AUTM has issued a statement on march-in with respect to remdesivir. To date, AUTM has never supported march-in. This new statement is no exception. Howard Bremer, an AUTM founder back when AUTM was SUPA, worked on the implementing regulations for … Continue reading

Posted in Bayh-Dole, high priced medicines, Policy | Tagged , , | Comments Off on AUTM weighs in on march-in for remdesivir

On Technology Transfer Metrics, 3: Money

Universities don’t track their transfers, the federal government does not track university transfers, and professional organizations and nonprofits do not track university transfers. Law firms don’t track university transfers. Venture capital firms don’t track university transfers. Pretty much anyone who … Continue reading

Posted in Metrics, Technology Transfer | Tagged , , , | Comments Off on On Technology Transfer Metrics, 3: Money

On Technology Transfer Metrics, 1: Issues

Let’s follow up on the fact that there’s no publicly available–free–data source to track university to industry technology transfer. There’s no non-free data source to track such transfer, either. You would think there would be. To get at metrics, let’s … Continue reading

Posted in Metrics, Technology Transfer | Tagged , , , , | Comments Off on On Technology Transfer Metrics, 1: Issues

Freely available data resources to track US university technology transfer

I answered a Quora question. Here it is. Are there any freely available data resources to track technology transfer activity between universities and commercial businesses in the US? Here’s my answer. No. And that’s quite amazing. Most universities publish an … Continue reading

Posted in Technology Transfer | Tagged , , , , | Comments Off on Freely available data resources to track US university technology transfer

Bayh-Dole disruptions of research and innovation

Bayh-Dole allows nonprofits and small businesses to retain title to inventions made in federally funded work. That is, the nonprofit or small business must first obtain title on their own. For businesses, this is straightforward as businesses routinely assign employees … Continue reading

Posted in Bayh-Dole | Tagged , , | Comments Off on Bayh-Dole disruptions of research and innovation

Fantasy depictions of technology transfer, 2

The standard accounts of the “technology transfer process” seem so clear and plausible that you may well believe they are generally accurate, even if there might be “technical details” that they gloss over. But these standard accounts are largely, almost … Continue reading

Posted in Bayh-Dole, Innovation, Policy | Tagged , , , , | Comments Off on Fantasy depictions of technology transfer, 2

Nine Points to Consider (with regard to AUTM’s licensing survey), 8-9

We are considering nine points with regard to AUTM’s annual licensing survey. We have got through seven points–not validated and with estimates, duplicate reporting, conflating technology and invention, activity measures giving the illusion of a process at work, no reporting … Continue reading

Posted in Bayh-Dole, Metrics, Policy | Tagged , , , , | Comments Off on Nine Points to Consider (with regard to AUTM’s licensing survey), 8-9

Nine Points to Consider (with regard to AUTM’s licensing survey), 1-7

The Association of University Technology Managers, a front group for university licensing professionals, conducts an annual survey of the universities that its members work for. The survey asks for various metrics regarding inventions, patenting, licensing, startups, and revenue. The survey … Continue reading

Posted in Bayh-Dole, Metrics, Policy | Tagged , , , , | Comments Off on Nine Points to Consider (with regard to AUTM’s licensing survey), 1-7

Nonsense about Bayh-Dole from Bio, 2018 edition–2

We are working through the 2018 version of Bio’s misinfographic about Bayh-Dole and its relationship to drug prices. Bio report metrics from an AUTM report as if they are facts. But these are not facts–they are estimates from an unvalidated … Continue reading

Posted in Bayh-Dole, Bozonet | Tagged , , , | Comments Off on Nonsense about Bayh-Dole from Bio, 2018 edition–2